who can prescribe tirzepatide What Is Used for? Approved and Potential Uses Mounjaro for Weight Loss Near

It is generally recommended for: Adults with obesity: Body Mass Index (BMI) of 30 or higher Adults who are overweight: BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol Mounjaro works alongside a reduced-calorie diet and increased physical activity to help achieve and maintain weight loss

For readers primarily concerned about safety, the next section covers FDA approval status in detail

Whether one or the other works for you depends on whether you can afford the medication, take it consistently, and change your lifestyle for long-term use

Clinical observations show an average return of about 5 kg within 6 months after stopping

Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist designed to reduce appetite and promote satiety, not increase hunger